The EU pharmaceutical legislation is undergoing its most significant reform in more than two decades, reshaping the regulatory framework for medicines across Europe.
This webinar will provide a concise overview of the new rules and their practical implications, covering key areas such as regulatory protection and incentives, patient access, innovation, orphan medicines and paediatric development, security of supply, antimicrobial resistance and environmental sustainability.
Join us to explore the key changes, the latest legislative developments, and what pharmaceutical companies should consider as they prepare for implementation.
Join ASPHALION experts Núria Coderch and Carmen Bas for this webinar, where they will cover the following topics:
- Understand the key changes introduced by the reform of EU pharmaceutical legislation.
- Explore the potential impact on regulatory data protection, incentives for innovation, patient access, and orphan and paediatric development.
- Review the new measures aimed at improving medicine availability, strengthening security of supply, and addressing antimicrobial resistance and environmental sustainability.
- Identify the practical considerations and next steps for pharmaceutical companies preparing for the new regulatory framework.
If you have any questions, please contact us at [email protected]
REGISTER HERE: https://bit.ly/3VyYbzJ
